Gudny Stella Gudnadottir1,2,3, Thorarinn Gudnason4, Katarina Wilhelmson1,3, Annica Ravn-Fischer5,6. 1. Department of Acute Medicine and Geriatrics, Section of Geriatrics, Sahlgrenska University Hospital, Gothenburg, Sweden. 2. School of Health Sciences, University of Iceland, Reykjavik, Iceland. 3. Center for Aging and Health AgeCAP, University of Gothenburg, Gothenburg, Sweden. 4. Laeknasetrid, Outpatient Cardiologoy Clinic, Reykjavik, Iceland. 5. Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. 6. Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg, Sweden.
Abstract
AIMS: This study aimed to examine the multimorbidity as well as the 30-day and 1-year readmission rates in a large, unselected cohort of elderly patients with acute coronary syndrome (ACS). METHODS AND RESULTS: All patients ≥70 years hospitalized due to ACS during January 1, 2006, to December 31, 2013, and registered in the SWEDEHEART registry were included. In-hospital multimorbidity and disease burden were determined. Outcomes included 30-day and 1-year all-cause mortality, any readmission, and readmissions due to ACS, heart failure, ischaemic stroke or transient ischaemic attack (TIA), and bleeding events. Out of 80,176 patients, 25.6% had ST-elevation myocardial infarction (STEMI) and 74.4% non-ST-segment elevation ACS (NSTE-ACS). The mean age was 79.8 (±6.4 standard deviation) and 43.4% were women. Multimorbidity, or two chronic diseases, was present in 67.7%, thereof in 53.0% of STEMI patients and 72.7% of NSTE-ACS patients. In-hospital mortality was 7.0%. Of the 74,577 patients who survived to discharge, 24.6% were readmitted within 30 days and 59.5% were readmitted during the following year. Multimorbid patients had a higher risk of readmissions than those without multimorbidity. Multimorbid STEMI patients were admitted the following year in 56.2% of cases compared to 44.5% of STEMI patients without multimorbidity, adjusted odds ratio (OR) 1.35 (95% confidence interval: 1.26-1.45). Multimorbid patients with NSTE-ACS were readmitted in 63.4% of cases the following year compared with 49.1% of those without multimorbidity, adjusted OR 1.42 (1.35-1.50). More than half of the readmissions were due to cardiovascular causes (ACS, stroke, TIA, or heart failure) or bleeding events. CONCLUSIONS: Older people with ACS have a high multimorbidity burden and a high readmission rate both within 30 days and 1 year. Half of the readmissions were due to a cardiovascular event or a bleeding event. The presence of multimorbidity increases the risk of readmissions for patients with ACS. As hospital admissions are costly for the health care system and can include risks, especially for older patients, there may be opportunities in better risk stratifying this group at discharge for subsequent decrease in readmission rates.
AIMS: This study aimed to examine the multimorbidity as well as the 30-day and 1-year readmission rates in a large, unselected cohort of elderly patients with acute coronary syndrome (ACS). METHODS AND RESULTS: All patients ≥70 years hospitalized due to ACS during January 1, 2006, to December 31, 2013, and registered in the SWEDEHEART registry were included. In-hospital multimorbidity and disease burden were determined. Outcomes included 30-day and 1-year all-cause mortality, any readmission, and readmissions due to ACS, heart failure, ischaemic stroke or transient ischaemic attack (TIA), and bleeding events. Out of 80,176 patients, 25.6% had ST-elevation myocardial infarction (STEMI) and 74.4% non-ST-segment elevation ACS (NSTE-ACS). The mean age was 79.8 (±6.4 standard deviation) and 43.4% were women. Multimorbidity, or two chronic diseases, was present in 67.7%, thereof in 53.0% of STEMI patients and 72.7% of NSTE-ACS patients. In-hospital mortality was 7.0%. Of the 74,577 patients who survived to discharge, 24.6% were readmitted within 30 days and 59.5% were readmitted during the following year. Multimorbid patients had a higher risk of readmissions than those without multimorbidity. Multimorbid STEMI patients were admitted the following year in 56.2% of cases compared to 44.5% of STEMI patients without multimorbidity, adjusted odds ratio (OR) 1.35 (95% confidence interval: 1.26-1.45). Multimorbid patients with NSTE-ACS were readmitted in 63.4% of cases the following year compared with 49.1% of those without multimorbidity, adjusted OR 1.42 (1.35-1.50). More than half of the readmissions were due to cardiovascular causes (ACS, stroke, TIA, or heart failure) or bleeding events. CONCLUSIONS: Older people with ACS have a high multimorbidity burden and a high readmission rate both within 30 days and 1 year. Half of the readmissions were due to a cardiovascular event or a bleeding event. The presence of multimorbidity increases the risk of readmissions for patients with ACS. As hospital admissions are costly for the health care system and can include risks, especially for older patients, there may be opportunities in better risk stratifying this group at discharge for subsequent decrease in readmission rates.
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White Journal: J Am Coll Cardiol Date: 2018-08-25 Impact factor: 24.094
Authors: D M Walker; C P Gale; G Lip; F J Martin-Sanchez; H F McIntyre; C Mueller; S Price; J Sanchis; M T Vidan; C Wilkinson; U Zeymer; H Bueno Journal: Eur Heart J Acute Cardiovasc Care Date: 2018-02-16
Authors: Walter A Rocca; Cynthia M Boyd; Brandon R Grossardt; William V Bobo; Lila J Finney Rutten; Véronique L Roger; Jon O Ebbert; Terry M Therneau; Barbara P Yawn; Jennifer L St Sauver Journal: Mayo Clin Proc Date: 2014-09-11 Impact factor: 7.616
Authors: Dragana Radovanovic; Burkhardt Seifert; Philip Urban; Franz R Eberli; Hans Rickli; Osmund Bertel; Milo A Puhan; Paul Erne Journal: Heart Date: 2013-11-01 Impact factor: 5.994
Authors: Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie Journal: Lancet Date: 2012-05-10 Impact factor: 79.321
Authors: Tomas Jernberg; Mona F Attebring; Kristina Hambraeus; Torbjorn Ivert; Stefan James; Anders Jeppsson; Bo Lagerqvist; Bertil Lindahl; Ulf Stenestrand; Lars Wallentin Journal: Heart Date: 2010-08-27 Impact factor: 5.994
Authors: Danielle A Southern; Jennifer Ngo; Billie-Jean Martin; P Diane Galbraith; Merril L Knudtson; William A Ghali; Matthew T James; Stephen B Wilton Journal: J Am Heart Assoc Date: 2014-09-18 Impact factor: 5.501
Authors: Carole E Aubert; Jeffrey L Schnipper; Niklaus Fankhauser; Pedro Marques-Vidal; Jérôme Stirnemann; Andrew D Auerbach; Eyal Zimlichman; Sunil Kripalani; Eduard E Vasilevskis; Edmondo Robinson; Joshua Metlay; Grant S Fletcher; Andreas Limacher; Jacques Donzé Journal: BMC Public Health Date: 2019-06-13 Impact factor: 3.295